The Board denied the appeal regarding the reduction of the rating for prostate cancer from 100 percent to 40 percent, effective December 1, 2024.
The deciding factor: The treatment for the Veteran's service-connected prostate cancer had ceased in 2023, he was afforded a mandatory VA examination, provided with 3.105(e) notice, and had no recurrence or metastasis of his prostate cancer.
- Claimed conditions
- Not specified in this decision
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- 40%
- Decision date
- July 8, 2025
- Citation
- A25058119
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.